IN BRIEF: Oxford Cannabinoid shareholder requests general meeting
18th Feb 2022 19:40
Oxford Cannabinoid Technologies Holdings PLC - pharmaceutical company developing prescription cannabinoid medicines - Receives letter from Gavin Sathianathan, chair and CEO of GHS Capital Ltd, holder of 78.1 million shares in Oxford Cannabinoid, reflecting an 8.1% stake. Read More